Sentien Biotechnologies Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

Sentien Biotechnologies's estimated annual revenue is currently $1.7M per year.(i)
Sentien Biotechnologies's estimated revenue per employee is $155,000

Employee Data

Sentien Biotechnologies has 11 Employees.(i)
Sentien Biotechnologies grew their employee count by -15% last year.

Sentien Biotechnologies's People

Name	Title	Email/Phone
1 Brian Miller	CEO, Co-Founder	Reveal Email/Phone

Sentien Biotechnologies Competitors & AlternativesAdd Company

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Dermavant Scien...	$81.4M	375	40%	N/A	N/A
#2 Metrum Research...	$16.9M	109	22%	N/A	N/A
#3 Clovis Oncology	$156.1M	120	-70%	$145M	N/A
#4 ArcherDX	$2.9M	37	-24%	$150M	N/A
#5 Inscripta	$1.3M	17	0%	$459.5M	N/A
#6 Cerapedics	$49.2M	254	15%	$180.7M	N/A
#7 Stone Clinical ...	$7M	45	-2%	N/A	N/A
#8 Apellis Pharmac...	$256.3M	840	9%	$168.5M	N/A
#9 CreoSalus	$4.2M	27	-7%	N/A	N/A
#10 MSBiotec	$10.1M	65	5%	N/A	N/A

Add Company

Show More Biotech Companies

What Is Sentien Biotechnologies?

Sentien's mission is to harness the power of cell therapy with innovative drug delivery systems to treat a wide range of acute inflammatory diseases. Our lead product is designed to allow for controlled, sustained delivery of mesenchymal stem cell (MSC) secreted factors. This approach immobilizes the MSCs in an extracorporeal device, allowing for doses of therapeutic secreted factors that are unattainable by direct injection.

keywords:N/A

N/A

Total Funding

Number of Employees

$1.7M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator